Clinical Trial Update: Safety and PK of Intrathecal CNTX-3001 for Intractable Chronic Low Back Pain [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and pharmacokinetics of intrathecal CNTX-3001 for intractable chronic low back pain; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• CNTX-3001

Snippet

Sponsor: Centrexion Therapeutics | Conditions: Lower Back Pain | Phase 1 | Status: RECRUITING